Xeris Pharmaceuticals | XERS - Прибыль до налогообложения





Прибыль до налогообложения Изменить Дата
Celltrion KRW 14.6B 180.89B 2025-06
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 8.54B 580M 2025-12
Eli Lilly USD 8.27B 1.03B 2025-12
Kangmei Pharma CNY 2.07M 13.77M 2025-09
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Medical Developments International AUD -149K 466K 2025-06
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Organigram Holdings CAD -41.72M 25.52M 2025-09
Pacira USD 571K 8.95M 2025-12
Perrigo USD 22.4M 19.2M 2025-09
Pharma Mar EUR 40.2M 44.28M 2025-12
Qiagen NV USD 109.17M 25.56M 2025-12
Sartorius EUR 157.8M 76.1M 2026-03
Supernus Pharmaceuticals USD -1.91M 56.04M 2025-12
Tilray USD -39.96M 39.19M 2025-09
Zealand Pharma A/S -406.5M 39.77M 2025-12
Zz Pientze Pharmaceu CNY 523.11M 659.54M 2025-06